A

Advanced ENT and Allergy | Breckenridge

Research site

(Unclaimed)

Location

2944 Breckenridge Lane, Louisville, Kentucky, United States of America

Site insights

Top conditions

Top treatments

OTO-313

Dupilumab

OTO-413

AD109

Omalizumab

Aroxybutynin

Fluticasone Propionate

Verekitug

GB001

Mometasone furoate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 26 total trials

A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)

Post-market study to continue to evaluate the effectiveness of the RhinAer ARC Stylus for chronic rhinitis.

Active, not recruiting

Chronic Rhinitis

Device: RhinAer ARC Stylus

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps (VIBRANT)

The primary purpose of this study is to assess the effect of verekitug (UPB-101) on the endoscopically determined size and extend of nasal polyps in...

Active, not recruiting

Chronic Rhinosinusitis with Nasal Polyps

Drug: Placebo

Drug: Verekitug (UPB-101)

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine

Safety and Efficacy Study of PRV111 and PRV211 in Subjects with Oral Squamous Cell Carcinoma

Arm 1 ( Phase 2/3 Run in ):PRV111: Topical Locoregional Delivery Placed Over the Tumor Region Primary Endpoint: Overall Response Rate (ORR) Primary O...

Enrolling

Oral Squamous Cell Carcinoma

Drug: PRV111 (Cisplatin Transmucosal System)

Drug: PRV211 (Intraoperative Cisplatin System)

Status recently updated